Related Experiment Video
Updated: Feb 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Disentangling Links Between Lung Cancer and Infectious Pneumonia via Real-World Data and Integrative Genomics
Yi-Fei Diao1, Zhe Chen2, Yi-Fan Tang3
1Department of Cardiothoracic Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China, nju.edu.cn.
Lung cancer (LC) significantly increases the risk of developing infectious pneumonia and adverse outcomes. This tumor-driven inflammation challenges the routine cessation of anticancer therapy, necessitating comorbidity-focused treatments.
Area of Science:
- Oncology
- Pulmonology
- Infectious Diseases
- Genetics
Background:
- Lung cancer (LC) patients frequently experience infectious pneumonia, often leading to treatment interruptions.
- The precise impact of LC on pneumonia development and prognosis remains incompletely understood.
Purpose of the Study:
- To investigate if LC is a critical factor in infectious pneumonia onset and adverse outcomes.
- To explore the causal relationship between LC and pneumonia using Mendelian randomization.
- To identify potential shared therapeutic targets for LC and pneumonia comorbidities.
Main Methods:
- Analysis of two intensive care unit databases for real-world associations.
- Mendelian randomization (MR) to establish causality.
- Post-Genome-Wide Association Studies (GWAS) analyses for comorbidity interactions and drug targets.
Main Results:
- LC identified as an independent risk factor for infectious pneumonia and 28-day mortality.
- MR confirmed causal links between genetically predicted LC and increased pneumonia risk and mortality.
- A strong genetic correlation between LC and chronic obstructive pulmonary disease (COPD) was observed, indicating a two-way interplay in pneumonia progression.
Conclusions:
- Infection-related pulmonary inflammation in LC patients may be partly tumor-driven.
- Findings challenge the routine cessation of anticancer therapy in these patients.
- Comorbidity-oriented treatment strategies, potentially targeting complement and coagulation cascades, are recommended.
More Related Videos
Related Concept Videos
Genomics
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
X-linked Traits
Lung Capacity

